Physician profile
Thomas Mancini
NPI 1265540868
$3,137.08
in general payments reported to CMS, 2019-2025
14 companies · $609 in 2025
The $609 reported for 2025 was more than what 77% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $106 · 2021: $371 · 2022: $976 · 2023: $293 · 2024: $478 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,380.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $792.93 | 2019-2025 | Iodosorb Ointment 40g USA, Collagenase Santyl, Stravix |
| Treace Medical Concepts, INC. | $740.05 | 2022 | |
| Organogenesis INC. | $605.08 | 2019-2025 | Puraply, Affinity, Novachor |
| Misonix INC | $200.96 | 2019-2021 | |
| Orthofix Medical, INC. | $125.00 | 2019 | |
| Horizon Therapeutics Plc | $124.99 | 2021 | |
| Kci USA, INC. | $97.33 | 2022 | |
| Integra Lifesciences Corporation | $96.69 | 2019-2024 | Tcc-Ez |
| Lifenet Health | $93.34 | 2024 | Theragenesis Wound Matrix |
| Hydrofera LLC | $90.71 | 2024-2025 | Leukomed Sorbact, Hydrofera Blue, Cutimed Sorbact |
| Kerecis Limited | $86.22 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Reapplix INC. | $46.87 | 2025 | 3c Patch Kit - Box |
| Cashflow Solutions, LLC | $19.23 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Solventum Corporation | $17.68 | 2024 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mancini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.